Back to Archived Journals » Core Evidence » Volume 2 » Issue 4

Review

Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration

       
Total article views   HTML views PDF downloads Totals
8,270 Dovepress* 8,270+ 2,287 10,557
Totals 8,270 2,287 10,557
*Since 15 December 2007
+Since July 2016

View citations on Google Scholar